ATAI Life Sciences N.V. Live Stock Price Today, Share Analysis and Chart

Name: ATAI Life Sciences N.V.: Is Infosys Ltd. worth buying?
Item: ATAI Life Sciences N.V.
Rating: 1.73058325
Author: Trendlyne DVM scores

about

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebuf...

7.25 0.00 (0.00%)

New 52W High today

198.4K

XNAS Volume

XNAS 11 Aug, 2026 9:58 AM (EDT)

Board Meeting

The next board meeting for ATAI Life Sciences N.V. is on 14 Aug 2026 for the purpose of ATAI Life Sciences NV Second Quarter Earnings Results for 2026 See details

Not Eligible

Expensive Valuation

2.8 / 100

Technically Moderately Bullish

66.4 / 100

1Yr Price target upside is 32%

8 analysts

ATAI Life Sciences N.V. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

ATAI Life Sciences N.V. Live Stock Price Today, Share Analysis and Chart

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebuf...

New 52W High today

SWOT Analysis

ATAI Life Sciences N.V. Live Price Chart

ATAI Life Sciences N.V. Live Price Chart